-
公开(公告)号:US12128215B2
公开(公告)日:2024-10-29
申请号:US17487570
申请日:2021-09-28
Applicant: Insulet Corporation
Inventor: Steven Cardinali , David Nazzaro , Ian McLaughlin
IPC: A61M5/172
CPC classification number: A61M5/1723 , A61M2205/0238 , A61M2205/3313 , A61M2230/201
Abstract: Embodiments of the present disclosure relate to approaches for more efficiently measuring glucose levels using a wearable drug delivery device. In some embodiments, the wearable drug delivery device may include a needle deployment component including a cannula and an optical conduit deployable into a user, the cannula operable to deliver a liquid drug to the user. The wearable drug delivery device may further include a glucose monitor including an optical sensor, the optical sensor operable to measure a light output received via the optical conduit.
-
公开(公告)号:US11129943B2
公开(公告)日:2021-09-28
申请号:US15980469
申请日:2018-05-15
Applicant: Insulet Corporation
Inventor: David Nazzaro , Ian McLaughlin , Simon Kozin , Maureen McCaffrey , Jackie Mac , Alexander Doudoumopoulos , Bhavin Patel
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.
-
公开(公告)号:US10342926B2
公开(公告)日:2019-07-09
申请号:US15607169
申请日:2017-05-26
Applicant: Insulet Corporation
Inventor: David Nazzaro , Ian McLaughlin , Simon Kozin , Maureen McCaffrey , Jackie Mac , Alexander Doudoumopoulos , Bhavin Patel
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.
-
公开(公告)号:USD851752S1
公开(公告)日:2019-06-18
申请号:US29671670
申请日:2018-11-29
Applicant: Insulet Corporation
Designer: David Nazzaro , Jeff Barnes , Maureen McCaffrey , Melinda Freson , Alexander Patt Broerman
-
公开(公告)号:US20170340837A1
公开(公告)日:2017-11-30
申请号:US15607182
申请日:2017-05-26
Applicant: Insulet Corporation
Inventor: David Nazzaro , Ian McLaughlin , Simon Kozin , Maureen McCaffrey , Jackie Mac , Alexander Doudoumopoulus , Bhavin Patel
CPC classification number: A61M5/31531 , A61M5/14248 , A61M5/28 , A61M5/31593 , A61M5/32 , A61M5/42 , A61M37/00 , A61M2005/2474 , A61M2005/3142 , A61M2005/31518
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.
-
公开(公告)号:US11672917B2
公开(公告)日:2023-06-13
申请号:US17039570
申请日:2020-09-30
Applicant: Insulet Corporation
Inventor: Steven Cardinali , David Nazzaro , Daniel Allis , Maureen McCaffrey
IPC: A61M5/315
CPC classification number: A61M5/31576 , A61M5/315 , A61M5/31501 , A61M5/31535 , A61M5/31566 , A61M5/31593 , A61M5/31511 , A61M5/31533 , A61M5/31543
Abstract: Drive systems for a drug delivery device are provided. The drive systems can be positioned within a container that stores a liquid drug to be delivered to a user. The drive systems can be coupled to a plunger positioned within the container. The drive systems can be incrementally advanced to drive the plunger further into the container, thereby expelling a portion of the stored liquid drug from the container for delivery to the user. The container can be any type of container including a pre-filled, standardized drug cartridge. The drive systems and container can be components of a wearable drug delivery device.
-
公开(公告)号:US11633541B2
公开(公告)日:2023-04-25
申请号:US16794689
申请日:2020-02-19
Applicant: Insulet Corporation
Inventor: Maureen McCaffrey , David Nazzaro , Ian McLaughlin , Simon Kozin
Abstract: Drug delivery systems with reduced hold-up volumes are provided. The drug delivery systems include a cartridge configured to hold a liquid drug. A cartridge stopper is positioned in a first portion of the cartridge. A needle guide component is positioned within the cartridge stopper. A needle is positioned within a central opening of the needle guide. A plunger is positioned in a second portion of the cartridge. The plunger includes a fluid path pocket facing and aligned with the central opening of the needle guide component. The plunger is driven toward the cartridge stopper to expel the liquid drug from the cartridge through the needle. An end of the needle can be positioned within the fluid path pocket when the plunger is pushed against the cartridge stopper, ensuring that only a small volume of the liquid drug remains in the cartridge when delivery of the liquid drug is completed.
-
公开(公告)号:US11147931B2
公开(公告)日:2021-10-19
申请号:US16191891
申请日:2018-11-15
Applicant: Insulet Corporation
Inventor: Steven Cardinali , David Nazzaro , Lawrence S. Ring
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient or user is provided. A soft needle or cannula can be placed in fluid communication with the liquid drug and can be coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the container to the patient through the soft needle or cannula. The wearable drug delivery device can include components for preventing backflow and eliminating air within the liquid drug. As a result, the comfort of the patient can be enhanced and correct drug dosages can be provided when using the drug delivery device.
-
公开(公告)号:US10716896B2
公开(公告)日:2020-07-21
申请号:US15359187
申请日:2016-11-22
Applicant: INSULET CORPORATION
Inventor: Jason O'Connor , Daniel Allis , David Nazzaro , John R. Bussiere , John D'Arco
Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.
-
公开(公告)号:US10684271B2
公开(公告)日:2020-06-16
申请号:US15009979
申请日:2016-01-29
Applicant: Insulet Corporation
Inventor: David Nazzaro , John Bussiere , Jason B. O'Connor , John D. D'Arco
IPC: G01N33/487 , G01N33/49
Abstract: A medical device to test bodily fluid, the device comprising a light emitting source, the light emitting source arranged to emit light inside the medical device; a test strip port, the test strip port comprising a test strip port receptacle to receive a test strip; and the light emitting source and the test strip port arranged such that, when the light emitting source emits light, at least a portion of the light emitted from the light emitting source is redirected inside the medical device to provide redirected light inside the medical device, and at least a portion of the redirected light lights the test strip port from inside the medical device in a manner than the redirected light is visible outside the test strip port.
-
-
-
-
-
-
-
-
-